Mahesh Singhi
Singhi Advisors Pvt. Ltd.
Proventus Life Science
Deal Type
Company sale
Sector
Healthcare
Completion Date
23rd August 2022
Deal Value
Not disclosed
Company Background
Proventus Life Science is engaged in the business of manufacturing, researching, developing and selling of niche Active Pharmaceutical Ingredient (API) and is supplying to regulated and semi-regulated markets with ~80% exports. The Company is present into various therapeutics including anti-epileptic, anti-fungal, anti-muscarinic and veterinary
Deal Summary
Singhi Advisors advised Proventus Life Science on its sale to Proventus Laboratories
Latest Mergers Alliance News
Khronos Advisory (Thailand) has advised Electricity Generating Public Company Limited (EGCO) on USD95 million capital increase in PT Chandra Daya Investasi
Dresner Partners (USA) advised Connoisseurs Products on its sale to Willert Home Products
Ethica Group (Italy) advised Vicenza Mode, high-end knitwear manufacturer, in the sale of a majority stake to Sienna PE
